CareLit · DOI-Nachweis · TumorDiagnostik & Therapie
Del(5q) and Lenalidomid
DOI 10.1055/s-0032-1326665
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Giagounidis
ZeitschriftTumorDiagnostik & Therapie
Ausgabe09/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
The vast majority of patients with myelodysplastic syndromes (MDS) become transfusion dependent, and the immediate beneficial effect of packed red cell transfusions comes with the threat of additional organ damage through iron overload. Reducing transfusion needs improves therefore quality of life, delays iron overload, and, perhaps, prolongs survival. In IPSS Low- and Intermediate-1 risk patients with a del(5q) del…
Zitieren
Zitierempfehlung
A Giagounidis (2012) Del(5q) and Lenalidomid. TumorDiagnostik & Therapie (09). https://doi.org/10.1055/s-0032-1326665
Mit CareLit weiterarbeiten